Mark Trudeau
CIK 1540412 · President and CEO · last filed 2025-11-14
Mark Trudeau is a President and CEO who has filed 58 SEC Form 4 insider transactions across 3 companies since 2012. The most recent filing, for TEL, was dated Nov 14, 2025. Across all open-market trades the lifetime net is −$7.0M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $1.5M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$1.50M
3
58
-$7.00M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| TEL | Director | 7,123 | $210.38 | $1.50M | -$996.7K | 12 | 2025-11-14 |
| Keenova Therapeutics plc (MNK) Delisted | President and CEO | 11,312 | $0.34 | $3.8K | -$6.01M | 38 | 2022-06-21 |
| Covidien plc (COVw) Delisted | Senior Vice President | 29,262 | — | — | $0 | 8 | 2013-05-07 |
Recent Filings
58 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-11-14 | TEL | Mixed | +435 | -$95.2K | EDGAR |
| 2024-11-15 | TEL | Mixed | +771 | -$85.2K | EDGAR |
| 2024-04-29 | TEL | Sell (S) | −7,044 | -$996.7K | EDGAR |
| 2023-12-14 | TEL | Mixed | +1,143 | -$51.8K | EDGAR |
| 2022-11-16 | TEL | Mixed | +1,281 | -$53.3K | EDGAR |
| 2022-06-21 | Keenova Therapeutics plc (MNK) Delisted | Disp (D) | — | $0 | EDGAR |
| 2021-12-13 | TEL | Mixed | +935 | -$49.0K | EDGAR |
| 2020-11-16 | Keenova Therapeutics plc (MNK) Delisted | Sell (S) | −217,072 | -$27.4K | EDGAR |
| 2020-11-12 | TEL | Mixed | +1,338 | -$47.3K | EDGAR |
| 2020-01-07 | Keenova Therapeutics plc (MNK) Delisted | Tax (F) | −5,246 | -$17.4K | EDGAR |